Jazz Pharma To Pay $1B For Rare Disease Drug Co.

Jazz Pharmaceuticals PLC plans to buy drug maker Gentium SpA for roughly $1 billion in a cash deal aimed at expanding its rare disease drug portfolio.

http://www.manufacturing.net/news/2013/12/jazz-pharma-to-pay-1b-for-rare-disease-drug-co